Chemical Compound

lamivudine

CAS Registry Number 134678-17-4

Back to search Request a Quote

Primary Record

lamivudine

In stock: 9,853 g
Purity: 98.7 %
CAS: 134678-17-4

Compound Identifiers & Properties

CAS: 134678-17-4
PubChem CID: 60825
SMILES: C1[C@H](O[C@H](S1)CO)N2C=CC(=NC2=O)N
Canonical SMILES: Nc1ccn([C@@H]2CS[C@H](CO)O2)c(=O)n1

Names & Synonyms

lamivudine
Epivir
Zeffix
Heptovir
Epivir-HBV
134678-17-4
Hepitec
Heptodin
Lamivir
Zefix
Heptivir
Lamivudine teva
Lamivudina
Lamivudinum
Combivir
Trizivir
Epzicom
VIROLAM
lamivudine oral
Kuvan
CIS-LAMIVUDINE
Epivir HBV
Lamivudine ViiV
Mixture Name
Lamivudine RS
Epivir(TM)
Lamivudine CRS
Epivir;
HHA & Lamivudine
Lamivudine & GNA
3TC Lamivudine
Epivir (TN)
DTHC
Lamivudine, 3TC
BCH-189
Heptovir (TN)
(-)-2'-Deoxy-3'-thiacytidine
Zeffix (TN)
2',3'-Dideoxy-3'-thiacytidine
3'-Thia-2',3'-dideoxycytidine
C8H11N3O3S
Epivir-HBV (TN)
GR-109714X
GR109714X
Lamivudine (Standard)
Lamivudine [USAN:BAN:INN]
(-)-BCH-189
Lamivudine (EPIVIR)
3TC and NV-01
BCH 189
L-SDDC
(-)-SddC
LAMIVUDINE [MI]
Lamivudine [USAN:INN:BAN]
AC1L1TZZ
LAMIVUDINE [INN]
LAMIVUDINE [JAN]
RefChem:798426
BCH189
LAMIVUDINE [HSDB]
LAMIVUDINE [USAN]
136891-12-8
beta-L-2',3'-Dideoxy-3'-thiacytidine
beta-L-3'-Thia-2',3'-dideoxycytidine
(-)NGPB-21
Lamivudine (JAN/USP/INN)
3TC & GNA
3TC & SST
HHA & 3TC
LAMIVUDINE [VANDF]
CHEBI:63577
CHEMBL141
D07TQV
D0V7DY
Epitope ID:613392
(+/-)-SddC
HSDB 7155
LAMIVUDINE [MART.]
CCRIS 9274
GR 109714X
LAMIVUDINE [USP-RS]
LAMIVUDINE [WHO-DD]
LAMIVUDINE [WHO-IP]
Lamivudine, cis-(+/-)-
US4RZW252L
4-amino-1-((2R,5S)-2-(hydroxymethyl)-1,3-oxathiolan-5-yl)pyrimidin-2(1H)-one
MFCD00869739
BCH 189, (-)-
DTXSID7023194
UNII-2T8Q726O95
DRG-0126
MLS000759424
MLS001424097
MLS006011910
BIDD:GT0033
LAMIVUDINE [EMA EPAR]
SCHEMBL109675
2',3' Dideoxy 3' thiacytidine
3TC
BCH-790
Lamivudine, (2S-cis)-Isomer
(-)-BCH 189
GG-714
JTEGQNOMFQHVDC-NKWVEPMBSA-N
3-TC
AC1Q6C34
AMY384
Lamivudine - Bio-X trade mark
Lamivudine [USAN:USP:INN:BAN]
orb1310390
PYR356
TRIUMEQ COMPONENT LAMIVUDINE
(-)-beta-L-BCH-189
2T8Q726O95
LAMIVUDINE [EP IMPURITY]
LAMIVUDINE [ORANGE BOOK]
LAMIVUDINE TEVA PHARMA B.V.
NSC-760061
TRIZIVIR COMPONENT LAMIVUDINE
CTK3J2124
GTPL12673
HY-B0250R
ZINC12346
DELSTRIGO COMPONENT LAMIVUDINE
J05AF05
LAMIVUDINE [EP MONOGRAPH]
2 -Deoxy-3 -thiacytidine
KIVEXA COMPONENT LAMIVUDINE
MFCD00870542
DTXCID001508532
GLXC-05058
HMS2051D21
HMS3259F08
HMS3713C16
LAMIVUDINE [USP MONOGRAPH]
EPZICOM COMPONENT LAMIVUDINE
LAMIVUDINUM [WHO-IP LATIN]
TEMIXYS COMPONENT LAMIVUDINE
(-)-NGPB-21
ALBB-038661
CID60825
COMBIVIR COMPONENT LAMIVUDINE
HY-B0250
MSK10170
C8-H11-N3-O3-S
Lamivudine for system suitability RS
4-amino-1-[(2R,5S)-2-(hydroxymethyl)-1,3-oxathiolan-5-yl]pyrimidin-2-one
ANW-43098
BBF-04130
BBL033871
BDBM50366817
CL0014
EBC-03887
NSC620753
s1706
SBB066293
STK801940
CPD000466319
lamivudine & TNF-alpha & IFN-gamma
4-Amino-1-(cis-2-(hydroxymethyl)-1,3-oxathiolan-5-yl)pyrimidin-2(1H)-one
4-AMINO-1-[(2R,5S)-2-(HYDROXYMETHYL)-1,3-OXATHIOLAN-5-YL]-2(1H)-PYRIMIDINONE
AKOS005622556
AKOS015854841
Efavirenz/lamivudine/tenofovir fumarate
Lamivudine, >=98% (HPLC), powder
(+/-)-3TC
(+/-)-BCH-189
(-)-BCH189
AC-1416
ACN-029244
AN-7245
CCG-100984
CS-2230
DB00709
KS-1073
LS-2107
NC00234
NC00705
NL06295
NSC 760061
RL01569
RTC-020973
(-)-1-((2R,5S)-2-(Hydroxymethyl)-1,3-oxathiolan-5-yl)cytosine
(-)-2 -Deoxy-3 -thiacytidine
KS-0000023D
Lamivudine for system suitability 1 CRS
4-AMINO-1-[(2R,5S)-2-(HYDROXYMETHYL)-1,3-OXATHIOLAN-5-YL]-1,2-DIHYDROPYRIMIDIN-2-ONE
NCGC00159341-04
NCGC00159341-05
NCGC00159341-18
NCGC00159341-20
(-)-beta-L-2',3'-Dideoxy-3'-thiacytidine
AJ-08348
BC206089
BCH 189 (-)-
BL164607
CJ-00130
EMTRICITABINE IMPURITY C [WHO-IP]
SAM001246582
SAM002589994
SC-15184
SMR000466319
ZB000700
3TC (AIDS INITIATIVE) (AIDS INITIATIVE)
J457.051K
(-)-1-[(2R,5S)-2-(Hydroxymethyl)-1,3-oxathiolan-5-yl]cytosine
1 3-Oxathiolane 2(1H)-pyrimidinone deriv.
L0217
NS00007004
rac-cis-Lamivudine ((2RS,5SR)-Lamivudine)
ST24030826
SW197614-3
4-amino-1-[(2R,5S)-2-(hydroxymethyl)-1,3-oxathiolan-5-yl]pyrimidin-2(1H)-one
C07065
D00353
EN300-123034
J10244
Lamivudine 100 microg/mL in Acetonitrile:Water
M-9795
P17147
24222-EP2269989A1
24222-EP2272516A2
24222-EP2272825A2
24222-EP2292227A2
24222-EP2298761A1
24222-EP2298783A1
24222-EP2305243A1
24222-EP2305640A2
24222-EP2305680A2
24222-EP2314590A1
4-Amino-1-((2R,5S)-2-(hydroxymethyl)-1,3-oxathiolan-5-yl)-2(1H)-pyrimidinone
AB00639995-06
AB00639995-08
AB00639995_09
beta-L-2 ,3 -Dideoxy-3 -thiacytidine
LAMIVUDINE/ZIDOVUDINE TEVA COMPONENT LAMIVUDINE
200973-EP2272825A2
678L174
A998898
F227713
Q422631
SR-01000759420
(-)-2 ,3 -Dideoxy-3 -thia-L-cytidine
2-Hydroxymethyl-5-(cytosin-1-yl)-1 3-oxathiolane
A1199077
SR-01000759420-5
2(1H)-Pyrimidinone, 4-amino-1-(2-(hydroxymethyl)-1,3-oxathiolan-5-yl)-, (2R-cis)-
BRD-K02992638-001-11-8
3TC, Zeffix, Heptovir, Epivir, Epivir-HBV, Lamivudine
Z1509637175
(-)-(2'R,5'S)-1-[2'-Hydroxymethyl-5'-(1,3-oxathiolanyl)]cytosine
2(1H)-Pyrimidinone, 4-amino-1-((2R,5S)-2-(hydroxymethyl)-1,3-oxathiolan-5-yl)-
2(1H)-Pyrimidinone, 4-amino-1-[(2R,5S)-2-(hydroxymethyl)-1,3-oxathiolan-5-yl]-, rel-
cis(-)-2-Hydroxymethyl-5-(cytosin-1-yl)-1 3-oxathiolane
Lamivudine Working Standard (Secondary Reference Standard)
Lamivudine, British Pharmacopoeia (BP) Reference Standard
Lamivudine, European Pharmacopoeia (EP) Reference Standard
(2R,5S)-1-[2-(Hydroxymethyl)-1,3-oxathiolan-5-yl]cytosine
.beta.-L-(-)-2',3'-dideoxy-3'-thiacytidine & Sho-Saiko-To
1-[(2R)-2-(Hydroxymethyl)-1,3-oxathiolane-5beta-yl]cytosine
Beta-L-(-)-2',3'-dideoxy-3'-thiacytidine & Sho-Saiko-To
cis(+/-)-2-Hydroxymethyl-5-(cytosin-1-yl)-1,3-oxathiolane
cis-(+/-)-2-Hydroxymethyl-5-(cytosin-1-yl)-1,3-oxathiolane
Lamivudine, United States Pharmacopeia (USP) Reference Standard
(+/-) (Cis)-1-[2-(Hydroxymethyl)-1,3-oxathiolan-5-yl]cytosine
(+/-)-(Cis)-1-[2-(Hydroxymethyl)-1,3-oxathiolan-5-yl]cytosine
(-)-1-((2R,5S)-2-(Hydroxymethyl)-1,3-oxathiolan-5-yl)cystosine
(-)-1-[(2R,5S)-2-Hydroxymethyl-1,3-oxathiolan-5-yl]cytosine
(-)-L-2',3'-DIDEOXY-3'-THIACYTIDINE; LAMIVUDINE; EPIVIR
(2R,cis)-4-amino-1-(2-hydroxymethyl-1,3-oxathiolan-5-yl)-(1H)-pyrimidin-2-one
1-[(2R)-2beta-(Hydroxymethyl)-1,3-oxathiolan-5beta-yl]cytosine
2(1H)-Pyrimidinone, 4-amino-1-[(2R,5S)-2-(hydroxymethyl)-1,3-oxathiolan-5-yl]-
2(1H)-Pyrimidinone,4-amino-1-[(2R,5S)-2-(hydroxymethyl)-1,3-oxathiolan-5-yl]-, rel-
Lamivudine, 1.0 mg/mL in methanol, certified reference material
(-)-1-[(2R,5S)-2beta-(Hydroxymethyl)-1,3-oxathiolan-5beta-yl]cytosine
131086-21-0
Lamivudine, Pharmaceutical Secondary Standard; Certified Reference Material
LMV
(+/-)-(cis)-4-Amino-1-(2-hydroxymethyl-1,3-oxathiolan-5-yl)-(1H)-pyrimidin-2-one
(-)-4-Amino-1-[(2R)-2beta-hydroxymethyl-1,3-oxathiolan-5beta-yl]-pyrimidin-2(1H)-one
1-[(2R)-2beta-Hydroxymethyl-1,3-oxathiolan-5beta-yl]-4-aminopyrimidin-2(1H)-one
2(1h)-pirimidinona, 4-amino-1-[(2r,5s)-2-(hidroximetil)-1,3-oxatiolan-5-il]-
2(1H)-Pyrimidinone 4-amino-1-[2-(hydroxymethyl)-1 3-oxathiolan-5-yl]-(2R-cis)-
2(1H)-Pyrimidinone, 4-amino-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl], (+/-) (Cis)
2(1H)-Pyrimidinone, 4-amino-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl], (+/-)-(Cis)
2(1H)-Pyrimidinone, 4-amino-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl], (-)(2R,5S)
2(1H)-Pyrimidinone, 4-amino-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl], (-)-(2R,5S)
2(1H)-Pyrimidinone, 4-amino-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl]-, cis-
2(1H)-Pyrimidinone, 4-amino-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl]-, cis-(+/-)-
3-[(5S,2R)-2-(hydroxymethyl)(1,3-oxathiolan-5-yl)]-6-amino-3-hydropyrimidin-2- one
4-Amino 1-[2beta-(hydroxymethyl)-1-oxa-3-thiacyclopentane-5beta-yl]pyrimidine-2(1H)-one
4-amino-1-((2R,5S)-2-(hydroxymethyl)-1,3-oxathiolan-5-yl)-1,2-dihydropyrimidin-2-one
4-amino-1-((2R,5S)-2-(hydroxymethyl)-1,3-oxathiolan-5-yl)pyrimidin-2-one
4-Amino-1-[(2R)-2beta-(hydroxymethyl)-1,3-oxathiolane-5beta-yl]pyrimidine-2(1H)-one
4-amino-1-[(2R,5S)-2-(hydroxymethyl)-[1,3]-oxathiolan-5-yl]-(1H)-pyrimidin-2-one
4-amino-1-[(2R,5S)-2-(hydroxymethyl)-1,3-Oxathiolan-5-yl]-(1H)-pyrimidin-2-one
4-Amino-1-[(2R,5S)-2-hydroxymethyl-1,3-oxathiolane-5-yl]pyrimidine-2(1H)-one
4-Amino-1-[2beta-(hydroxymethyl)-1,3-oxathiolane-5beta-yl]pyrimidine-2(1H)-one
cis(+/-)-4-amino-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl]-2(1H)-pyrimidinone
Lamivudine for system suitability 1, European Pharmacopoeia (EP) Reference Standard
Lamivudine for system suitability 2, European Pharmacopoeia (EP) Reference Standard
Lamivudine, 98%, a potent nucleoside analog reverse transcriptase inhibitor - 100MG 100mg
rel-4-Amino-1-[(2R,5S)-2-(hydroxymethyl)-1,3-oxathiolan-5-yl]-2(1H)-pyrimidinone
1117764-41-6
134680-32-3
2(1H)-Pyrimidinone, 4-amino-1-[(2R,5S)-2-(hydroxymethyl)-1,3-oxathiolan-5-yl]-, rel-; 2(1H)-Pyrimidinone, 4-amino-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl]-, cis-(+/-)-; 1,3-Oxathiolane, 2(1H)-pyrimidinone deriv.; rel-4-Amino-1-[(2R,5S)-2-(hydroxymethyl)-1,3-oxathiolan-5-yl]-2(1H)-pyrimidinone; 2(1H)-Pyrimidinone, 4-amino-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl]-, cis-; BCH 189; cis(+/-)-2-Hydroxymethyl-5-(cytosin-1-yl)-1,3-oxathiolane; cis-(+/-)-Lamivudine; (2RS,5SR)-Lamivudine
2(1H)-Pyrimidinone, 4-amino-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl], (-)(2R,5S) & Galanthus Nivalis Agglutinin (GNA)
2(1H)-Pyrimidinone, 4-amino-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl], (-)(2R,5S) & Hippeastrum hybrid agglutinin( HHA)
2(1H)-Pyrimidinone, 4-amino-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl], (-)-(2R,5S) & Galanthus Nivalis Agglutinin (GNA)
2(1H)-Pyrimidinone, 4-amino-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl], (-)-(2R,5S) & Hippeastrum hybrid agglutinin(HHA)
4-AMINO-1-((2R,5S)-2-(HYDROXYMETHYL)-1,3-OXATHIOLAN-5-YL)PYRIMIDIN-2(1H)-ONE [WHO-IP]
603-844-3
Lamivudine; 2(1H)-Pyrimidinone, 4-amino-1-[(2R,5S)-2-(hydroxymethyl)-1,3-oxathiolan-5-yl]-; 2(1H)-Pyrimidinone, 4-amino-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl]-, (2R-cis)-; 1,3-Oxathiolane, 2(1H)-pyrimidinone deriv.; (-)-2'-Deoxy-3'-thiacytidine; (-)-BCH 189; 2-Hydroxymethyl-5-(cytosin-1-yl)-1,3-oxathiolane; 3TC; BCH 189, (-)-; Epivir; Epivir HBV; GR 109714X; Hepitec; Heptodin; Heptovir; L-SddC; Lamivir; Virolam; Zeffix; Zefix; cis(-)-2-Hydroxymethyl-5-(cytosin-1-yl)-1,3-oxathiolane; beta-L-2',3'-Dideoxy-3'-thiacytidine; beta-L-3'-Thia-2',3'-dideoxycytidine; GR 109714X; 3TC; GR 111720X; GR 135522X; Lamivudine GR109714X; BP Zidovudine and Lamivudine Impurity Standard; Ph Eur Lamivudine for system suitability 1; BP Lamivudine Impurity Standard; Ph Eur Lamivudine for system suitability 2